Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hyperfine, Inc. Director's Dealing 2021

Dec 28, 2021

34088_dirs_2021-12-27_4ba92743-ed44-45c7-aca3-27dd44a3c18f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hyperfine, Inc. (HYPR)
CIK: 0001833769
Period of Report: 2021-12-22

Reporting Person: HC Sponsor LLC (10% Owner)
Reporting Person: HealthCor Group, LLC (10% Owner)
Reporting Person: Cohen Arthur Bruce (10% Owner)
Reporting Person: Healey Joseph Patrick (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-22 Class A common stock C 5534000 Acquired 5534000 Direct
2021-12-22 Class A Common Stock A 1000000 Acquired 6534000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-22 Class A ordinary shares $ C 614000 Disposed Class A Ordinary Shares (614000) Direct
2021-12-22 Class B ordinary shares $ C 4920000 Disposed Class A Ordinary Shares (4920000) Direct

Footnotes

F1: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis.

F2: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4.

F3: The Reporting Persons have voting and dispositive power over the reported securities, which were acquired by affiliates of the Reporting Persons pursuant to a PIPE Investment in connection with the completion of the Business Combination.